Psychedelic Medicine
| Discipline | Psychedelic drugs, medicine |
|---|---|
| Language | English |
| Edited by | Peter Hendricks, Charles D. Nichols |
| Publication details | |
| History | 2023–present |
| Publisher | Mary Ann Liebert on behalf of the International Society for Research on Psychedelics |
| Frequency | Quarterly |
| Hybrid | |
| Standard abbreviations | |
| ISO 4 | Psychedelic Med. |
| Indexing | |
| ISSN | 2831-4425 (print) 2831-4433 (web) |
| LCCN | 2022200469 |
| OCLC no. | 1304260166 |
| Links | |
Psychedelic Medicine is a quarterly peer-reviewed medical journal on the use of serotonergic psychedelics as therapeutic agents in medicine.[1][2][3][4] Its editors-in-chief are Peter Hendricks (University of Alabama at Birmingham) and Charles D. Nichols (Louisiana State University).[1][3][4] The journal was established in 2023[1][4][5] and is published by Mary Ann Liebert.[1][4][5] It is the first medical journal to be focused exclusively on psychedelics.[1]
References
- ^ a b c d e Davies, Kevin (1 January 2022). "No Hallucination: The Launch of Psychedelic Medicine". GEN Edge. 4 (1): 892–895. doi:10.1089/genedge.4.1.150.
- ^ Price, Stephanie (5 May 2022). "New peer-reviewed psychedelics journal to launch in 2023". Psychedelic Health. Retrieved 10 November 2024.
- ^ a b "Psychedelic Medicine Is Focus of New Journal". Mirage News (Press release). 31 October 2022. Retrieved 10 November 2024.
- ^ a b c d "Peter Hendricks named co-editor-in-chief of new journal, Psychedelic Medicine". Home - The University of Alabama at Birmingham (Press release). 3 April 2023. Retrieved 10 November 2024.
- ^ a b "New peer-reviewed journal Psychedelic Medicine launching in 2023". EurekAlert! (Press release). Retrieved 10 November 2024.